Opinion

Video

Overview of CAR T-cell Therapies in R/R B-cell ALL

Author(s):

Elias Jabbour, MDEvandro D. Bezerra, MD

Evandro D. Bezerra, MD, provides an overview of current CAR T-cell therapies for relapsed/refractory B-cell acute lymphoblastic leukemia and explores emerging CAR T products under investigation.

  1. Dr. Jabbour to Dr. Bezerra:Can you walk us through the currently available CAR T-cell Therapies for Relapsed / Refractory B-cell ALL, as well as some CAR T products currently being investigated?
    1. Please comment on Brexucabtagene autoleucel (TECARTUS®), Tisagenlecleucel (KYMRIAH®), [Obecabtagene autoleucel (Obe-cel) ; Obe-Cel FDA Biologics License Application BLA News Release]
Related Videos
5 KOLs are featured in this program
5 KOLs are featured in this program
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
5 KOLs are featured in this series.
5 KOLs are featured in this panel.
5 KOLs are featured in this panel.
2 KOLs are featured in this panel.
2 KOLs are featured in this panel.
This series features 2 KOLs
Related Content
Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment
September 15th 2021

Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment